Myomo, Inc. (AMEX: MYO) AI-Powered Stock Analysis
See how Myomo, Inc. scores across key metrics like financial growth, valuation, and market position on the AMEX, using AI-driven evaluation.
MYO●AMEX
HealthcareMedical - Devices
$1.42
$0.36(33.96%)
U.S. Market opens in 52h 17m
Myomo, Inc. (AMEX: MYO) AI-Powered Stock Analysis
See how Myomo, Inc. scores across key metrics like financial growth, valuation, and market position on the AMEX, using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full DisclaimerMyomo, Inc. (AMEX: MYO) Stock Overall Grade
Myomo, Inc.'s grade for its AMEX listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Myomo, Inc.'s overall AMEX stock rating.
Forecast
C+Score
50/100Financial Growth
AScore
80/100Fundamental Growth
BScore
69/100Key Ratios
CScore
42/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Myomo, Inc. (AMEX: MYO) AI-Powered Stock Analysis
On the AMEX, MYO demonstrates Good performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (80/100, A) and Fundamental Growth (69/100, B) highlight its stability, while Key Ratios (42/100, C) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), the AMEX-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests High divergence in outlook.(AMEX: MYO) Component Analysis Explained
Understand the key factors behind each Myomo, Inc. (AMEX: MYO) stock grade, including financials, comparisons, and forecasts.